Table 2.
Clinical characteristics of the patients with T2DM (N = 248).
| Variables | Frequency (n) | Percentage (%) |
|---|---|---|
| Family history of T2DM | ||
| Yes | 48 | 19.4 |
| No | 200 | 80.6 |
| Health insurance | ||
| Yes | 179 | 72.2 |
| No | 69 | 27.8 |
| Comorbidities | ||
| Yes | 154 | 62.1 |
| No | 94 | 37.9 |
| Type of comorbidities | ||
| Hypertension | 137 | 55.2 |
| HIV/AIDS | 36 | 14.5 |
| CKD | 24 | 9.7 |
| Others | 11 | 4.4 |
| Having diabetes complications | ||
| Yes | 122 | 49.2 |
| No | 126 | 50.8 |
| Type of diabetes complications | ||
| Nephropathy | 21 | 17.2 |
| Retinopathy | 49 | 40.2 |
| Neuropathy | 13 | 10.7 |
| Retinopathy + neuropathy | 15 | 12.3 |
| Neuropathy + nephropathy | 24 | 19.7 |
| Living condition | ||
| Living alone | 47 | 19.0 |
| Supported by a family member | 201 | 81.0 |
| Adherence to regular follow-up | ||
| Yes | 91 | 36.7 |
| No | 157 | 63.3 |
| Duration of T2DM since diagnosis (years) | ||
| ≤ 5 | 78 | 31.5 |
| > 5 | 170 | 68.5 |
| Route of anti-T2DM medication | ||
| Oral | 191 | 77.0 |
| Intravenous | 33 | 13.3 |
| Mixed | 24 | 9.7 |
| Current medications used | ||
| Metformin | 204 | 82.3 |
| Insulin | 43 | 17.3 |
| Gemer 1 | 1 | 0.4 |
| Duration of treatment (years) | ||
| < 5 | 43 | 17.3 |
| 5–10 | 140 | 56.5 |
| > 10 | 65 | 26.2 |
Other comorbidities: peptic ulcer disease- 6 cases, arthritis-3 cases, and epilepsy-2 cases.